Literature DB >> 9024121

Clinical uses of intravenous immunoglobulin in pregnancy.

A L Clark1, S A Gall.   

Abstract

Intravenous immunoglobulin was licensed for use in the United States in 1981. Currently, there are only a few Food and Drug Administration-labeled indications for intravenous immunoglobulin, but up to 50 "off-label" uses are reported in the literature. The obstetric literature contains numerous reports on intravenous immunoglobulin therapy during pregnancy. This article reviews the properties, pharmacokinetics, mechanisms of action, and side effects of intravenous immunoglobulin, as well as the reported uses of intravenous immunoglobulin during pregnancy.

Mesh：

Substances：

Year:  1997        PMID： 9024121     DOI： 10.1016/s0002-9378(97)80043-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  9 in total

1.  Advances in the Development of Therapeutics for Cytomegalovirus Infections.

Authors:  Edward Acosta; Terry Bowlin; Jennifer Brooks; Lillian Chiang; Islam Hussein; David Kimberlin; Lawrence M Kauvar; Randi Leavitt; Mark Prichard; Richard Whitley
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

Review 2.  Immunoglobulin therapy in immunohematological disorders.

Authors:  V P Choudhry; M Mahapatra; R Kashyap
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

3.  A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.

Authors:  Lawrence M Kauvar; Keyi Liu; Minha Park; Neal DeChene; Robert Stephenson; Edgar Tenorio; Stote L Ellsworth; Takako Tabata; Matthew Petitt; Mitsuru Tsuge; June Fang-Hoover; Stuart P Adler; Xiaohong Cui; Michael A McVoy; Lenore Pereira
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

Review 4.  Pharmacological Approach to Managing Childhood-Onset Systemic Lupus Erythematosus During Conception, Pregnancy and Breastfeeding.

Authors:  Nicole Bitencourt; Bonnie L Bermas
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

5.  A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories.

Authors:  Mary H H Ensom; Mary D Stephenson
Journal:  Hum Reprod       Date:  2011-07-18       Impact factor: 6.918

Review 6.  NK cells, autoantibodies, and immunologic infertility: a complex interplay.

Authors:  Caterina De Carolis; Carlo Perricone; Roberto Perricone
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

7.  Seroprevalence of cytomegalovirus among pregnant women attending Murtala Mohammed Specialist Hospital Kano, Nigeria.

Authors:  K M Hamid; A B Onoja; U A Tofa; K N Garba
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

Review 8.  Screening for cytomegalovirus during pregnancy.

Authors:  Stuart P Adler
Journal:  Infect Dis Obstet Gynecol       Date:  2011-08-09

Review 9.  Cytomegalovirus in pregnancy: to screen or not to screen.

Authors:  Susan P Walker; Ricardo Palma-Dias; Erica M Wood; Paul Shekleton; Michelle L Giles
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-18       Impact factor: 3.007
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.